News
-
Let’s Talk: Addressing mental health in the HIV community
In recognition of Bell Let’s Talk Day, we look at what steps can be taken to improve mental…
-
ENGAGing men in HIV prevention and care
CTN 300: The Engage Study is investigating the use of PrEP among urban Canadian gay, bisexual, and other…
-
Does the COVID-19 vaccine work for people living with HIV?
A new national study, called HIVCOV (CTN 328), will assess COVID-19 vaccine immune responses and effectiveness among people…
-
Understanding the impacts of prenatal antiretroviral medications on children
A new CTN study investigates how exposure to HIV and antiretroviral drugs during pregnancy could have long-term effects…
-
TEACHHing service providers how to best care for trans people
March 31 marks the International Transgender Day of Visibility, an annual event dedicated to celebrating transgender (trans) people…
-
Seven ways the Community Advisory Committee strengthens HIV research
Here are the seven ways that the CTN works towards the meaningful involvement of people living with HIV…
-
Treating liver disease in people living with HIV
The CTNPT 024 team investigated whether vitamin E could be a treatment option for NASH, a type of…
-
New research comparing HIV medications set to change international recommendations
The WHO-funded study shows that dolutegravir is the optimal choice for first-line treatment of HIV
-
Examining the results of CTN 297: Black PRAISE
The Black PRAISE team have pioneered a novel intervention aimed at reducing HIV-related stigma while strengthening the HIV…
